Quantcast

Latest Ischaemic heart disease Stories

2010-06-18 23:55:00

BEIJING, June 19 /PRNewswire-Asia/ -- Seven out of 10 men admitted to hospital for a heart attack (acute ST segment elevation myocardial infarction (STEMI)) had erectile dysfunction (ED) in the six months prior to their admission according to new data presented today at the World Congress of Cardiology (WCC) Scientific Sessions in Beijing, China. A year-long study conducted in 2009 involving 111 sexually active men at the University Malaya Medical Centre, admitted for STEMI,...

2010-06-07 03:18:00

TEL AVIV, Israel, June 7, 2010 /PRNewswire-FirstCall/ -- BSP Biological Signal Processing Ltd. (http://www.bsp.co.il), develops and markets innovative systems for non-invasive diagnosis and monitoring of Ischemic Heart Disease (IHD) based on its proprietary HyperQ(TM) technology. BSP recently presented the results of a study on the economic and clinical benefits of the HyperQ(TM) stress test in the diagnosis and management of coronary heart disease (CHD) at the International Congress on...

486389ae00595f09fb84c7b1277e8bc41
2010-05-06 09:35:00

Psychosocial work environment and risk of ischemic heart disease in women High pressure jobs boost young women's risk of heart disease, finds a large study of female nurses published May 5 in Occupational and Environmental Medicine. Previous research has indicated a link between a demanding job and heart disease risk, but the findings have been largely confined to men. The research team assessed the impact of work pressure and degree of personal influence in the workplace on the heart health...

60a666cb698495b7817985ef33a6ec971
2010-04-12 11:05:00

An innovative treatment using stem cells undergoes testing at the research center of the CHUM, in collaboration with the Maisonneuve-Rosemont Hospital Some patients with heart muscles seriously affected by coronary heart disease may soon be able to benefit from an innovative treatment. Researchers at the Research Centre of the Centre hospitalier de l'Universit© de Montr©al (CRCHUM), in collaboration with the Maisonneuve-Rosemont Hospital (MRH) are evaluating the safety, feasibility...

2010-02-11 10:49:13

Heart disease is the leading cause of death in the United States. According to the Center for Disease Control about every 25 seconds, an American will have a coronary event; about one every minute will die from one. What can you do to reduce your chances of developing coronary heart disease? * Recognize the risk factors * Knowing the signs and symptoms of heart attack * Live a healthy lifestyle: Watch your diet, get plenty of exercise People who have survived a heart attack can also work to...

2010-01-26 08:00:00

SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx(TM) (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease. The update was presented by Gabor M. Rubanyi, M.D., Ph.D., Cardium's Chief Scientific Officer at the annual 2010 Cell & Gene Therapy Forum in...

2009-12-03 11:06:15

New Research Finds Better Prognosis for Diabetics with Heart Disease The outlook for individuals with type 2 diabetes and coronary artery disease is not as grim as originally believed, according to new Saint Louis University research published in Circulation, the Journal of the American Heart Association. "Our research found that people with type 2 diabetes and heart disease have a more favorable prognosis with proper medical care and management of risk factors, including cholesterol, blood...

2009-11-17 13:34:30

Previous data have proven that GRK2 inhibition is protective against chronic heart failure Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Translational Medicine at Thomas Jefferson University. The studies will be presented at the American Heart Association Scientific Sessions 2009 in Orlando, Fla. The first study was...

2009-11-09 06:00:00

DOYLESTOWN, Pa., Nov. 9 /PRNewswire/ -- Two products from Prescient Medical -- the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System -- will be featured at the 3rd Annual Canaccord Adams Cardiovascular Conference. The conference will take place on Tuesday, November 10th in San Francisco, California, and will bring together a select group of med-tech and biotech companies focused on the most important markets in cardiovascular medicine. Prescient Medical is one of...

2009-10-22 10:46:00

PLYMOUTH, Mass., Oct. 22 /PRNewswire/ -- Harvest Technologies Corp. (www.harvesttech.com) announced today that the Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to commence its BMAC Enhanced CABG Trial. This is a two phase 42-patient 'feasibility' clinical trial using the company's BMAC System to concentrate autologous bone marrow cells to treat patients with congestive heart failure undergoing treatment with coronary artery bypass...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related